{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:38:10Z","timestamp":1787002690159,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":862,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1038\/s41379-020-0560-x","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T06:03:43Z","timestamp":1588745023000},"page":"1832-1843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy"],"prefix":"10.1016","volume":"33","author":[{"given":"Laura A.","family":"Favazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Parseghian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina N.","family":"Nikiforova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5681-0112","authenticated-orcid":false,"given":"Somak","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail I.","family":"Wald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan S.","family":"Proksell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Dueker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse R.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall E.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Bahary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram C.","family":"Gorantla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Pingpank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon A.","family":"Choudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Paniccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie C.","family":"Ongchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer H.","family":"Zureikat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aatur D.","family":"Singhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-020-0560-x_bib1","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1038\/s41379-020-0560-x_bib2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/JOP.0942001","article-title":"Impact of irinotecan and oxaliplatin on overall survival in patients with metastatic colorectal cancer: a population-based study","volume":"5","author":"Lim","year":"2009","journal-title":"J Oncol Pr"},{"key":"10.1038\/s41379-020-0560-x_bib4","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Colon Cancer, Version 4.2019. 2019. Last access date 1\/1\/2020. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf."},{"key":"10.1038\/s41379-020-0560-x_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJMoa1305275","article-title":"Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer","volume":"369","author":"Douillard","year":"2013","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-020-0560-x_bib6","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1200\/JCO.2007.14.7116","article-title":"Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer","volume":"26","author":"Amado","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-020-0560-x_bib8","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/S0140-6736(11)60613-2","article-title":"Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial","volume":"377","author":"Maughan","year":"2011","journal-title":"Lancet"},{"key":"10.1038\/s41379-020-0560-x_bib9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1200\/JCO.2007.12.5906","article-title":"KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab","volume":"26","author":"Lievre","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib11","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1200\/JCO.2016.71.9807","article-title":"Molecular biomarkers for the evaluation of colorectal cancer: guideline from the american society for clinical pathology, college of american pathologists, association for molecular pathology, and the american society of clinical oncology","volume":"35","author":"Sepulveda","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/ijc.28106","article-title":"KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy","volume":"133","author":"Valtorta","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1038\/s41379-020-0560-x_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11530-0","article-title":"Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients","volume":"10","author":"Serebriiskii","year":"2019","journal-title":"Nat Commun"},{"key":"10.1038\/s41379-020-0560-x_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-12-292","article-title":"Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients","volume":"12","author":"Mekenkamp","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1038\/s41379-020-0560-x_bib15","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1002\/cncr.28371","article-title":"Colorectal carcinomas, KRAS p.G13D mutant allele-specific imbalance, and anti-epidermal growth factor receptor therapy","volume":"119","author":"Hartman","year":"2013","journal-title":"Cancer"},{"key":"10.1038\/s41379-020-0560-x_bib16","unstructured":"Tumours of the Colon and Rectum, In: WHO classification of tumours of the digestive system. 5th edn. Vol. 1. Lyon: International Agency for Research on Cancer; 2019;157\u201392."},{"key":"10.1038\/s41379-020-0560-x_bib17","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1136\/gutjnl-2016-313586","article-title":"Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia","volume":"67","author":"Singhi","year":"2018","journal-title":"Gut"},{"key":"10.1038\/s41379-020-0560-x_bib18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gutjnl-2018-317817","article-title":"Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures","volume":"69","author":"Singhi","year":"2020","journal-title":"Gut"},{"key":"10.1038\/s41379-020-0560-x_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J Mol Diagn"},{"key":"10.1038\/s41379-020-0560-x_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jmoldx.2014.09.008","article-title":"Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data","volume":"17","author":"Grasso","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1038\/s41379-020-0560-x_bib21","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/neuonc\/nov289","article-title":"Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors","volume":"18","author":"Nikiforova","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib22","doi-asserted-by":"crossref","first-page":"4830","DOI":"10.1158\/1078-0432.CCR-07-4906","article-title":"K-Ras mutations and treatment outcome in colorectal cancer patients receiving exclusive fluoropyrimidine therapy","volume":"14","author":"Etienne-Grimaldi","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/s41379-020-0560-x_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","article-title":"HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology","volume":"35","author":"Bartley","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N. Engl J Med"},{"key":"10.1038\/s41379-020-0560-x_bib25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ibd.20766","article-title":"Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon","volume":"15","author":"Ullman","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"10.1038\/s41379-020-0560-x_bib26","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gutjnl-2018-316191","article-title":"Evolutionary history of human colitis-associated colorectal cancer","volume":"68","author":"Baker","year":"2019","journal-title":"Gut"},{"key":"10.1038\/s41379-020-0560-x_bib27","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.canlet.2012.02.031","article-title":"Pan-colonic field defects are detected by CGH in the colons of UC patients with dysplasia\/cancer","volume":"320","author":"Lai","year":"2012","journal-title":"Cancer Lett"},{"key":"10.1038\/s41379-020-0560-x_bib28","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1158\/1541-7786.MCR-08-0532","article-title":"Oncogenic activating mutations are associated with local copy gain","volume":"7","author":"Modrek","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1038\/s41379-020-0560-x_bib29","doi-asserted-by":"crossref","first-page":"e9651","DOI":"10.1371\/journal.pone.0009651","article-title":"Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted","volume":"5","author":"Poage","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1038\/s41379-020-0560-x_bib30","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/JTO.0b013e3181f1cab3","article-title":"Evaluation of Kras gene mutation and copy number in thymic carcinomas and thymomas","volume":"5","author":"Sasaki","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.lungcan.2011.01.029","article-title":"Frequency and clinicopathologic correlates of KRAS amplification in non-small cell lung carcinoma","volume":"74","author":"Wagner","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1038\/s41379-020-0560-x_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/JTO.0b013e31820594f0","article-title":"Evaluation of Kras gene mutation and copy number gain in non-small cell lung cancer","volume":"6","author":"Sasaki","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1158\/2159-8290.CD-11-0170","article-title":"Genomic complexity and AKT dependence in serous ovarian cancer","volume":"2","author":"Hanrahan","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1038\/s41379-020-0560-x_bib34","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/annonc\/mdy222","article-title":"Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer","volume":"30","author":"Ricordel","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1038\/s41379-020-0560-x_bib35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.critrevonc.2014.07.005","article-title":"Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab: a systematic review and meta-analysis","volume":"93","author":"Abdel-Rahman","year":"2015","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1038\/s41379-020-0560-x_bib36","doi-asserted-by":"crossref","first-page":"e55128","DOI":"10.1371\/journal.pone.0055128","article-title":"Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysis","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS ONE"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0560-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222007128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41379-020-0560-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:39:41Z","timestamp":1760229581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222007128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0893395222007128"],"URL":"https:\/\/doi.org\/10.1038\/s41379-020-0560-x","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-020-0560-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}